SCHEMBL20105752

SCHEMBL20105752

C=CC[C@H](C)CCCC(C)n1c(N2CCCC2/C=C/F)nc2nc(C(=N)OC(N)=O)nc(C3C=NCC(Cl)C3)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20106308 0.68 MDM2 (0.43) —
SCHEMBL9238480 0.43 HRH3 (0.32) —
SCHEMBL16063842 0.42 KMT2A (0.39) —
SCHEMBL2004794 0.41 LMNA (0.55) —
SCHEMBL8212975 0.41 TSHR (0.39) —
SCHEMBL29138549 0.41 DPP4 (0.35) —
SCHEMBL8221276 0.41 TSHR (0.39) —
SCHEMBL28773870 0.41 TSHR (0.39) —
SCHEMBL7864519 0.41 PTPN1 (0.33) —
SCHEMBL7856847 0.41 TSHR (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951180-B1 2,6,7,8 SUBSTITUTED PURINES AS HDM2 INHIBITORS MERCK SHARP & DOHME (US) 2018-05-02 — — EP disclosed
Send feedback